Eric Benevich, Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 39,300 shares at $104.12 ($4.0M) on 2023-02-08, disclosed to the SEC on 2023-02-08.
Seasonal sale ($4.0M) by Chief Commercial Officer — this insider has traded NBIX in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $105.63 | 1,280 | $135K | 3.3% |
| 2 | $105.63 | 1,280 | $135K | 3.3% |
| 3 | $102.29 | 2,030 | $208K | 5.1% |
| 4 | $102.29 | 2,030 | $208K | 5.1% |
| 5 | $102.42 | 15,360 | $1.6M | 39.0% |
| 6 | $102.42 | 15,360 |
| $1.6M |
| 39.0% |
| 7 | $104.12 | 980 | $102K | 2.5% |
| 8 | $104.12 | 980 | $102K | 2.5% |
| Total | $102.70 avg | 39,300 | $4.0M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $503K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $232K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $369K | — | Filing → |